Hub gene associated with prognosis in bladder cancer is a novel therapeutic target
PeerJ · 2023
DOI: 10.7717/peerj.15670 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Dengpan Fang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health commission of Hubei Province scientific research project.
Abstract (Originalsprache)
Objective
Bladder cancer is a clinical and social conundrum due to its high incidence and recurrence rate. It is urgent to find new targets for the diagnosis and treatment of bladder cancer and improve the prognosis and survival rate of bladder cancer patients. We sought a prognosis-related gene, built related models of evaluated bladder cancer and identified the function of the hub gene in bladder cancer.
Methods
We downloaded the data of bladder cancer patients from the TCGA database, and used differentially expressed genes (DEGs), copy number variation (CNV) and survival analysis to scan the hub genes associated with prognosis in bladder cancer. Then, multi-factor cox regression was used to obtain the bladder cancer prognosis correlation model. Then, we analyzed the relationship between the expression of hub gene and immune microenvironment of bladder cancer. The relationship between the expression of hub gene and prognosis in bladder cancer patients was verified by immunohistochemistry. Cell proliferation assay and drug sensitivity test in vivo were used to verify the inhibition of bladder cancer by targeted inhibitors.
Results
In bladder cancer, we screened seven hub genes ( ACLY, CNP, NKIRAS2, P3H4, PDIA6, VPS25 and XPO1 ) associated with survival. Moreover, the multifactor regression model constructed with hub gene can well distinguish the prognosis of bladder cancer. Hub gene is mostly associated with immune microenvironment. Immunohistochemical results basically confirmed the importance of XPO1 in bladder cancer. Selinexor (an inhibitor of XPO1) could effectively inhibit the proliferation of bladder cancer in the cell proliferation experiments by CCK-8 assays and it could suppress the growth of bladder cancer in mouse bladder cancer model.
Conclusions
In this study, a prognostic model with seven hub genes has provided great help for the prognosis prediction of bladder cancer patients. And XPO1 is an important target affecting the prognosis of bladder cancer, and inhibition of XPO1 can effectively inhibit bladder cancer proliferation and growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
- Department of Urology, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, China.
- Center of Laboratory Animal Science, Nanchang University,, Nanchang, China.
- Jiangxi Province Key Laboratory of Laboratory Animal, Nanchang, China.
- Nanchang Royo Biotechnology, Nanchang, China.
- The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Förderung
- Health commission of Hubei Province scientific research project
Zitieren
APA
Fang, D., He, Y., Yi, Y., Mei, J., & Liu, C. (2023). Hub gene associated with prognosis in bladder cancer is a novel therapeutic target. PeerJ. https://doi.org/10.7717/peerj.15670
Vancouver
Fang D, He Y, Yi Y, Mei J, Liu C. Hub gene associated with prognosis in bladder cancer is a novel therapeutic target. PeerJ. 2023. doi:10.7717/peerj.15670
BibTeX
@article{Fang2023,
author = {Fang, Dengpan and He, Yuanqiao and Yi, Yun and Mei, Jiaqi and Liu, Cundong},
title = {Hub gene associated with prognosis in bladder cancer is a novel therapeutic target},
journal = {PeerJ},
year = {2023},
doi = {10.7717/peerj.15670}
}
EUVIMED